{"count": 14, "results": [{"_id": "36830619", "pmid": 36830619, "pmcid": "PMC9953052", "title": "Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review", "journal": "Biomolecules", "authors": ["Zhang Y", "Zhou F", "Guan J", "Zhou L", "Chen B"], "date": "2023-01-29T00:00:00Z", "doi": "10.3390/biom13020250", "meta_date_publication": "2023 Jan 29", "meta_volume": "13", "meta_issue": "2", "meta_pages": "", "score": 50282.984, "text_hl": "Herein, we discuss experimental ex vivo studies and clinical observations of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in different @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematologic malignancies@@@. ", "citations": {"NLM": "Zhang Y, Zhou F, Guan J, Zhou L, Chen B. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review Biomolecules. 2023 Jan 29;13(2):. PMID: 36830619", "BibTeX": "@article{36830619, title={Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review}, author={Zhang Y and Zhou F and Guan J and Zhou L and Chen B}, journal={Biomolecules}, volume={13}, number={2}}"}}, {"_id": "33747367", "pmid": 33747367, "pmcid": "PMC7967492", "title": "Metformin - its anti-cancer effects in hematologic malignancies", "journal": "Oncol Rev", "authors": ["Podhorecka M"], "date": "2021-02-26T00:00:00Z", "doi": "10.4081/oncol.2021.514", "meta_date_publication": "2021 Feb 26", "meta_volume": "15", "meta_issue": "1", "meta_pages": "514", "score": 50280.01, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ - its anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ effects in @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematologic malignancies@@@", "citations": {"NLM": "Podhorecka M. Metformin - its anti-cancer effects in hematologic malignancies Oncol Rev. 2021 Feb 26;15(1):514. PMID: 33747367", "BibTeX": "@article{33747367, title={Metformin - its anti-cancer effects in hematologic malignancies}, author={Podhorecka M}, journal={Oncol Rev}, volume={15}, number={1}, pages={514}}"}}, {"_id": "37364455", "pmid": 37364455, "title": "Repurposing Metformin in hematologic tumor: State of art.", "journal": "Curr Probl Cancer", "authors": ["Hu M", "Chen Y", "Ma T", "Jing L"], "date": "2023-06-20T00:00:00Z", "doi": "10.1016/j.currproblcancer.2023.100972", "meta_date_publication": "2023 Jun 20", "meta_volume": "47", "meta_issue": "4", "meta_pages": "100972", "score": 50278.992, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematologic tumor@@@: State of art.", "citations": {"NLM": "Hu M, Chen Y, Ma T, Jing L. Repurposing Metformin in hematologic tumor: State of art. Curr Probl Cancer. 2023 Jun 20;47(4):100972. PMID: 37364455", "BibTeX": "@article{37364455, title={Repurposing Metformin in hematologic tumor: State of art.}, author={Hu M and Chen Y and Ma T and Jing L}, journal={Curr Probl Cancer}, volume={47}, number={4}, pages={100972}}"}}, {"_id": "36474458", "pmid": 36474458, "title": "Metformin: new applications for an old drug.", "journal": "J Basic Clin Physiol Pharmacol", "authors": ["Naseri A", "Sanaie S", "Hamzehzadeh S", "Seyedi-Sahebari S", "Hosseini MS", "Gholipour-Khalili E", "Rezazadeh-Gavgani E", "Majidazar R", "Seraji P", "Daneshvar S", "Rezazadeh-Gavgani E"], "date": "2022-12-07T00:00:00Z", "doi": "10.1515/jbcpp-2022-0252", "meta_date_publication": "2022 Dec 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.113, "text_hl": "There is evidence of the beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@, early-stage @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, @DISEASE_Urethral_Neoplasms @DISEASE_MESH:D014523 @@@urothelial cancer@@@, @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@blood cancer@@@, @DISEASE_Melanoma @DISEASE_MESH:D008545 @@@melanoma@@@, and @DISEASE_Bone_Neoplasms @DISEASE_MESH:D001859 @@@bone cancer@@@, suggesting @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potent anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ agent. ", "citations": {"NLM": "Naseri A, Sanaie S, Hamzehzadeh S, Seyedi-Sahebari S, Hosseini MS, Gholipour-Khalili E, Rezazadeh-Gavgani E, Majidazar R, Seraji P, Daneshvar S, Rezazadeh-Gavgani E. Metformin: new applications for an old drug. J Basic Clin Physiol Pharmacol. 2022 Dec 7;():. PMID: 36474458", "BibTeX": "@article{36474458, title={Metformin: new applications for an old drug.}, author={Naseri A and Sanaie S and Hamzehzadeh S and Seyedi-Sahebari S and Hosseini MS and Gholipour-Khalili E and Rezazadeh-Gavgani E and Majidazar R and Seraji P and Daneshvar S and Rezazadeh-Gavgani E}, journal={J Basic Clin Physiol Pharmacol}}"}}, {"_id": "35079096", "pmid": 35079096, "pmcid": "PMC8789909", "title": "Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)", "journal": "Sci Rep", "authors": ["Allende-Vega N", "Marco Brualla J", "Falvo P", "Alexia C", "Constantinides M", "de Maudave AF", "Coenon L", "Gitenay D", "Mitola G", "Massa P", "Orecchioni S", "Bertolini F", "Marzo I", "Anel A", "Villalba M"], "date": "2022-01-25T00:00:00Z", "doi": "10.1038/s41598-022-05470-x", "meta_date_publication": "2022 Jan 25", "meta_volume": "12", "meta_issue": "1", "meta_pages": "1341", "score": 50244.508, "text_hl": "Finally, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreases the growth of @SPECIES_9606 @@@human@@@ @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematological tumor@@@ cells in xenograft models, mainly in presence of monoclonal antibodies that recognize @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ antigens. ", "citations": {"NLM": "Allende-Vega N, Marco Brualla J, Falvo P, Alexia C, Constantinides M, de Maudave AF, Coenon L, Gitenay D, Mitola G, Massa P, Orecchioni S, Bertolini F, Marzo I, Anel A, Villalba M. Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1) Sci Rep. 2022 Jan 25;12(1):1341. PMID: 35079096", "BibTeX": "@article{35079096, title={Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)}, author={Allende-Vega N and Marco Brualla J and Falvo P and Alexia C and Constantinides M and de Maudave AF and Coenon L and Gitenay D and Mitola G and Massa P and Orecchioni S and Bertolini F and Marzo I and Anel A and Villalba M}, journal={Sci Rep}, volume={12}, number={1}, pages={1341}}"}}, {"_id": "30208162", "pmid": 30208162, "pmcid": "PMC6113924", "title": "Metformin and blood cancers", "journal": "Clinics (Sao Paulo)", "authors": ["Cunha Júnior AD", "Pericole FV", "Carvalheira JBC"], "date": "2018-09-06T00:00:00Z", "doi": "10.6061/clinics/2018/e412s", "meta_date_publication": "2018 Sep 6", "meta_volume": "73", "meta_issue": "suppl 1", "meta_pages": "e412s", "score": 50088.3, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@blood cancers@@@", "citations": {"NLM": "Cunha Júnior AD, Pericole FV, Carvalheira JBC. Metformin and blood cancers Clinics (Sao Paulo). 2018 Sep 6;73(suppl 1):e412s. PMID: 30208162", "BibTeX": "@article{30208162, title={Metformin and blood cancers}, author={Cunha Júnior AD and Pericole FV and Carvalheira JBC}, journal={Clinics (Sao Paulo)}, volume={73}, number={suppl 1}, pages={e412s}}"}}, {"_id": "26086617", "pmid": 26086617, "pmcid": "PMC4707049", "title": "Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice", "journal": "Free Radic Biol Med", "authors": ["Xu G", "Wu H", "Zhang J", "Li D", "Wang Y", "Wang Y", "Zhang H", "Lu L", "Li C", "Huang S", "Xing Y", "Zhou D", "Meng A"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/j.freeradbiomed.2015.05.045", "meta_date_publication": "2015 Oct", "meta_volume": "87", "meta_issue": "", "meta_pages": "15-25", "score": 50061.5, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates ionizing irradiation-induced long-term @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematopoietic@@@ stem cell @DISEASE_Wounds_and_Injuries @DISEASE_MESH:D014947 @@@injury@@@ in mice", "citations": {"NLM": "Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, Zhang H, Lu L, Li C, Huang S, Xing Y, Zhou D, Meng A. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice Free Radic Biol Med. 2015 Oct;87():15-25. PMID: 26086617", "BibTeX": "@article{26086617, title={Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice}, author={Xu G and Wu H and Zhang J and Li D and Wang Y and Wang Y and Zhang H and Lu L and Li C and Huang S and Xing Y and Zhou D and Meng A}, journal={Free Radic Biol Med}, volume={87}, pages={15-25}}"}}, {"_id": "23177353", "pmid": 23177353, "title": "Metformin: the hidden chronicles of a magic drug.", "journal": "Eur J Intern Med", "authors": ["Mahmood K", "Naeem M", "Rahimnajjad NA"], "date": "2013-01-01T00:00:00Z", "doi": "10.1016/j.ejim.2012.10.011", "meta_date_publication": "2013 Jan", "meta_volume": "24", "meta_issue": "1", "meta_pages": "20-6", "score": 50059.414, "text_hl": "It also delays aging and is effective in aging related disorders and is equally effective in @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ related disorders at least in different rodent studies. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'s major effect has been shown in various @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancers@@@ ranging from solid to @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematological malignancies@@@. ", "citations": {"NLM": "Mahmood K, Naeem M, Rahimnajjad NA. Metformin: the hidden chronicles of a magic drug. Eur J Intern Med. 2013 Jan;24(1):20-6. PMID: 23177353", "BibTeX": "@article{23177353, title={Metformin: the hidden chronicles of a magic drug.}, author={Mahmood K and Naeem M and Rahimnajjad NA}, journal={Eur J Intern Med}, volume={24}, number={1}, pages={20-6}}"}}, {"_id": "25846811", "pmid": 25846811, "title": "Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.", "journal": "Exp Hematol", "authors": ["Kawashima I", "Mitsumori T", "Nozaki Y", "Yamamoto T", "Shobu-Sueki Y", "Nakajima K", "Kirito K"], "date": "2015-07-01T00:00:00Z", "doi": "10.1016/j.exphem.2015.03.005", "meta_date_publication": "2015 Jul", "meta_volume": "43", "meta_issue": "7", "meta_pages": "524-33.e1", "score": 50046.88, "text_hl": "Several studies have revealed that the activation of @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ by chemical stimulators, such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, induces apoptosis in a variety of @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematologic malignant@@@ cells. ", "citations": {"NLM": "Kawashima I, Mitsumori T, Nozaki Y, Yamamoto T, Shobu-Sueki Y, Nakajima K, Kirito K. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells. Exp Hematol. 2015 Jul;43(7):524-33.e1. PMID: 25846811", "BibTeX": "@article{25846811, title={Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.}, author={Kawashima I and Mitsumori T and Nozaki Y and Yamamoto T and Shobu-Sueki Y and Nakajima K and Kirito K}, journal={Exp Hematol}, volume={43}, number={7}, pages={524-33.e1}}"}}, {"_id": "31744691", "pmid": 31744691, "title": "Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest.", "journal": "J Pharmacol Sci", "authors": ["Zhou X", "Kuang Y", "Liang S", "Wang L"], "date": "2019-12-01T00:00:00Z", "doi": "10.1016/j.jphs.2019.10.003", "meta_date_publication": "2019 Dec", "meta_volume": "141", "meta_issue": "4", "meta_pages": "146-152", "score": 50044.434, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a widely used antidiabetic drug, has previously been demonstrated to exert anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ effects in certain @<m>DISEASE_Hematologic_Neoplasms</m> @DISEASE_MESH:D019337 @@@hematological malignancies@@@, but its effects on the transformation of @DISEASE_Myelodysplastic_Syndromes @DISEASE_MESH:D009190 @@@myelodysplastic syndromes@@@ to @DISEASE_Leukemia_Myeloid_Acute @DISEASE_MESH:D015470 @@@acute myeloid leukemia@@@ (@DISEASE_Leukemia_Myeloid_Acute @DISEASE_MESH:D015470 @@@AML-@@@@DISEASE_Myelodysplastic_Syndromes @DISEASE_MESH:D009190 @@@MDS@@@) remain unclear. ", "citations": {"NLM": "Zhou X, Kuang Y, Liang S, Wang L. Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest. J Pharmacol Sci. 2019 Dec;141(4):146-152. PMID: 31744691", "BibTeX": "@article{31744691, title={Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest.}, author={Zhou X and Kuang Y and Liang S and Wang L}, journal={J Pharmacol Sci}, volume={141}, number={4}, pages={146-152}}"}}]}